[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100532992":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":23,"centralContacts":28,"locations":10,"responsibleParty":34,"collaborators":36,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":54,"acronym":10,"eligibilityCriteria":55,"healthyVolunteers":52,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":66,"overallStatus":69,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":75,"leadSponsor":77,"locationsCount":10},{"fullName":5,"class":6},"Henan University of Traditional Chinese Medicine","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"TCM Group",null,"The study will include adult patients discharged after hospitalization for pneumonia, with no restrictions on TCM syndromes. Patients diagnosed with pneumonia via laboratory or imaging tests at admission and treated in the hospital will be eligible if enrolled within seven days of discharge. Follow-ups will occur every three months over one year, documenting treatment methods (TCM or Western medicine), hospitalizations, respiratory infections, mortality, and quality of life.\n\nSubgroup analyses will be conducted based on age, type of pneumonia (community- or hospital-acquired), specific TCM treatments (e.g., Chinese patent medicines or external therapies), and treatment duration.",[13],"Drug: TCM",{"label":15,"type":10,"description":16,"interventionNames":10},"Non-TCM Group","All patients who do not meet the defined criteria for the TCM group will be classified into the non-TCM group.",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"DRUG","TCM","We will perform subgroup analyses based on specific TCM interventions (such as Chinese patent medicines or external therapies) and the duration of TCM treatment (for example, comparing patients who receive continuous oral Chinese patent medicine for two months or more each year with those who do not). These analyses will assess the efficacy and safety of TCM.",[9],[24],{"name":25,"affiliation":26,"role":27},"Jiansheng Li, Doctor","The First Affiliated Hospital of Henan University of Traditional Chinese Medicine","STUDY_CHAIR",[29],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Minghang Wang, Doctor","CONTACT","+86 371 66248624","wmh107hn@163.com",{"type":35,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[37,39,42,44,46,48],{"name":38,"class":6},"Wuhan No.1 Hospital",{"name":40,"class":41},"Hebei Provincial Hospital of Traditional Chinese Medicine","OTHER_GOV",{"name":43,"class":6},"Shanghai University of Traditional Chinese Medicine",{"name":45,"class":6},"Qingdao Hiser Medical Group",{"name":47,"class":6},"The First Affiliated Hospital of Zhejiang Chinese Medical University",{"name":49,"class":6},"Shaanxi Hospital of Traditional Chinese Medicine","100532992","respiratory-disease-cohort-studies-of-chinese-medicine-for-pneumonia-research-pneumonia-100532992",false,"NCT06220019","REspiratory diSEAse cohoRt Studies of CHinese Medicine for Pneumonia (RESEARCH-Pneumonia)","Selection Criteria:\n\n* Hospitalized patients with a confirmed diagnosis of pneumonia (HAP, CAP).\n* Age ≥18 years.\n* Signed informed consent form.\n\nExclusion Criteria:\n\n* Patients with confusion, consciousness disorders, dementia, and various mental illnesses;\n* Patients with altered mental status, dementia, consciousness disorders, or various psychiatric conditions;\n* Those who are completely unable to care for themselves or are bedridden long-term; and those currently participating in other clinical drug trials.\n* Known to be allergic to treatment drugs.","ALL","18 Years","85 Years",{"count":60,"type":61},5000,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to evaluate the clinical efficacy and safety of dialectical treatment in the patients with pneumonia after discharge in a prospective cohort study: one is the Traditional Chinese Medicine (TCM) cohort, which has been evaluated and has certain effects; The other is a non traditional Chinese medicine queue.",[65],"Pneumonia",[65,67,68],"Chinese Medicine","Cohort","NOT_YET_RECRUITING","2024-12-26",{"date":72,"type":73},"2024-12-30","ACTUAL",{"date":70,"type":61},{"date":76,"type":61},"2027-12",{"name":5,"class":6}]